Your browser doesn't support javascript.
loading
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.
McDowell, P Jane; Busby, John; Hanratty, Catherine E; Djukanovic, Ratko; Woodcock, Ashley; Walker, Samantha; Hardman, Timothy Colin; Arron, Joseph R; Choy, David F; Bradding, Peter; Brightling, Chris E; Chaudhuri, Rekha; Cowan, Douglas; Mansur, Adel H; Fowler, Stephen J; Diver, Sarah E; Howarth, Peter; Lordan, James; Menzies-Gow, Andrew; Harrison, Timothy; Robinson, Douglas S; Holweg, Cecile T J; Matthews, John G; Pavord, Ian D; Heaney, Liam G.
Affiliation
  • McDowell PJ; Center for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, United Kingdom.
  • Busby J; Center for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, United Kingdom.
  • Hanratty CE; Center for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, United Kingdom.
  • Djukanovic R; School of Clinical and Experimental Sciences, University of Southampton, National Institute for Health and Care Research (NIHR) Southampton Biomedical Research Center, Southampton, United Kingdom.
  • Woodcock A; Manchester Academic Health Science Center and NIHR Manchester Biomedical Research Center, Manchester University Hospitals National Health Service (NHS) Foundation Trust, Manchester, United Kingdom.
  • Walker S; Asthma UK and British Lung Foundation Partnership, London, United Kingdom.
  • Hardman TC; Niche Science and Technology Ltd., Richmond, United Kingdom.
  • Arron JR; Genentech Inc., San Francisco, California.
  • Choy DF; Genentech Inc., San Francisco, California.
  • Bradding P; Department of Respiratory Sciences, Institute for Lung Health and Leicester NIHR Biomedical Research Center, University of Leicester, Leicester, United Kingdom.
  • Brightling CE; Department of Respiratory Sciences, Institute for Lung Health and Leicester NIHR Biomedical Research Center, University of Leicester, Leicester, United Kingdom.
  • Chaudhuri R; Gartnavel General Hospital, Glasgow and University of Glasgow, Glasgow, United Kingdom.
  • Cowan D; NHS Greater Glasgow and Clyde, Stobhill Hospital, Glasgow, United Kingdom.
  • Mansur AH; University of Birmingham and Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Fowler SJ; Manchester Academic Health Science Center and NIHR Manchester Biomedical Research Center, Manchester University Hospitals National Health Service (NHS) Foundation Trust, Manchester, United Kingdom.
  • Diver SE; Department of Respiratory Sciences, Institute for Lung Health and Leicester NIHR Biomedical Research Center, University of Leicester, Leicester, United Kingdom.
  • Howarth P; School of Clinical and Experimental Sciences, University of Southampton, National Institute for Health and Care Research (NIHR) Southampton Biomedical Research Center, Southampton, United Kingdom.
  • Lordan J; the Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Menzies-Gow A; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, the University of Manchester, Royal Brompton and Harefield Hospitals, London, United Kingdom.
  • Harrison T; Nottingham Respiratory NIHR Biomedical Research Center, University of Nottingham, Nottingham, United Kingdom.
  • Robinson DS; University College Hospitals NHS Foundation Trust, London, United Kingdom.
  • Holweg CTJ; Genentech Inc., San Francisco, California.
  • Matthews JG; 23andMe, Sunnyvale, California; and.
  • Pavord ID; Oxford Respiratory NIHR Biomedical Research Center, Nuffield Department of Medicine, the University of Oxford, Oxford, United Kingdom.
  • Heaney LG; Center for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, United Kingdom.
Am J Respir Crit Care Med ; 206(5): 545-553, 2022 09 01.
Article in En | MEDLINE | ID: mdl-35549845
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2022 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2022 Type: Article Affiliation country: United kingdom